HIGHLIGHTS
- who: Ni Jin et al. from the School of Basic Medical College, Chengdu University of Traditional Chinese Medicine, Chengdu, China have published the research: Exploring the Underlying Mechanism of Ren-Shen-Bai-Du Powder for Treating Inflammatory Bowel Disease Based on Network Pharmacology and Molecular Docking, in the Journal: Pharmaceuticals 2022, 15, 1038. of 15/09/2021
- what: The authors initially identified potential targets of RSBDP against IBD through network pharmacology analysis and molecular Afterwards the DSS-induced colitis mice model was employed to assess the effects of RSBDP. In this study, a total of . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.